110 results on '"Capuano, R."'
Search Results
2. Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey
- Author
-
Lavorgna, L., Esposito, S., Lanzillo, R., Sparaco, M., Ippolito, D., Cocco, E., Fenu, G., Borriello, G., De Mercanti, S., Frau, J., Capuano, R., Trojsi, F., Rosa, L., Clerico, M., Laroni, A., Morra, V. Brescia, Tedeschi, G., and Bonavita, S.
- Published
- 2019
- Full Text
- View/download PDF
3. Prostate cancer diagnosis through electronic nose in the urine headspace setting: a pilot study
- Author
-
Asimakopoulos, A D, Del Fabbro, D, Miano, R, Santonico, M, Capuano, R, Pennazza, G, D'Amico, A, and Finazzi-Agrò, E
- Published
- 2014
- Full Text
- View/download PDF
4. Investigating the structure-sensitivity relationship of metalloporphyrins based chemical sensors
- Author
-
Capuano, R., Santonico, M., Martinelli, D.E., D'Amico, A., Paolesse, R., Monti, D., and Di Natale, C.
- Published
- 2009
- Full Text
- View/download PDF
5. COPD diagnosis by a gas sensor array.
- Author
-
Capuano, R., Santonico, M., Martinelli, E., Pennazza, G., Paolesse, R., Bergamini, A., Cazzola, M., Ciaprini, C., Di Natale, C., and D’Amico, A.
- Abstract
Abstract: Like other pulmonary affections, Chronic Obstructive Pulmonary Disease (COPD) is hardly detectable during the first stages of manifestation, usually it is diagnosed observing both the respiratory function and the patient history. In the last years, even in spite of a lack of a clear compound-disease relationship, breath analysis with chemical sensors array have demonstrated the capability to identify some lung diseases. In this paper we illustrate that even in the case of COPD breath contains information that can be usefully exploited for diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
6. In situ hydraulic conductivity of clay and silty-clay fluvial-deltaic sediments, Texas Gulf Coast
- Author
-
Capuano, R. M. and Jan, R. Z.
- Published
- 1996
- Full Text
- View/download PDF
7. Geochemical reactions during biodegradation/vapor-extraction remediation of petroleum contamination in the vadose zone
- Author
-
Johnson, M. A. and Capuano, R. M.
- Subjects
PETROLEUM ,SOIL pollution ,ZONE of aeration - Published
- 1996
8. Electronic noses calibration procedure in the context of a multicentre medical study
- Author
-
Santonico, M., Pennazza, G., Capuano, R., Falconi, C., Vink, T.J., Knobel, H.H., Van der Schee, M.P., Sterk, P.J., Montuschi, P., and D’Amico, A.
- Subjects
- *
ELECTRONIC noses , *MICROBALANCES , *TRANSDUCERS , *METALLOPORPHYRINS , *GAS detectors , *MEDICAL equipment - Abstract
Abstract: An overview of the scientific literature in the medical field tells us that a large part of electronic nose applications is devoted to breath analysis. A network based study can help testing the validity of this strategy when using many different devices based on identical or different technologies, in view of a use in real clinical practice. The first step is the instrument calibration using a set of key-compounds. In this work a gas sensor array based on quartz microbalance transducers functionalized with metalloporphyrins (ROTV e-nose), and a Cyranose is used simultaneously in a calibration experiment with three ad hoc selected compounds: ethanol, hexane and ethyl acetate, at concentration levels around 1ppm. These tests have demonstrated that limits of detection down to tens of ppb are possible. Moreover, a mapping between the two instruments has been performed through the calculation of a model based on Cyranose data, and applied to the ROTV e-nose data, for the prediction of compound concentrations. This test has shown a good ability in concentrations prediction, with an error lower than 10ppb. In conclusion, this study provides the first step toward quality assurance of e-nose data in the medical setting. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
9. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling
- Author
-
Santonico, M., Lucantoni, G., Pennazza, G., Capuano, R., Galluccio, G., Roscioni, C., La Delfa, G., Consoli, D., Martinelli, E., Paolesse, R., Di Natale, C., and D’Amico, A.
- Subjects
- *
LUNG cancer diagnosis , *BRONCHOSCOPY , *AIR analysis , *PILOT projects , *ADENOCARCINOMA , *SQUAMOUS cell carcinoma - Abstract
Abstract: Lung cancer diagnosis via breath analysis has to overcome some issues that can be summarized by two crucial points: (1) further developments for more performant breath sampling technologies; (2) discovering more differentiated volatile fingerprints to be ascribed to specific altered biological mechanisms. The present work merges these two aspects in a pilot study, where a breath volume, sampled via endoscopic probe, is analyzed by an array of non-selective gas sensors. Even if the original non-invasive methods of breath analysis has been laid in favour of the endoscopic means, the innovative technique here proposed allows the analysis of the volatile mixtures directly sampled near the tumor mass. This strategy could open the way for a better understanding of the already obtained discrimination among positive and negative cancer cases. The results obtained so far confirm the established discrimination capacity. This allows to discriminate the different subtypes of lung cancer with 75% of correct classification between adenocarcinoma and squamous cell carcinoma. This result suggests that a ‘zoom-in’ on the cancer settled inside the human body can increase the resolution power of key-volatiles detection, allowing the discrimination among different cancer fingerprints. We report this novel technique as a robust support for a better comprehension of the promising results obtained so far and present in literature; it is not to be intended as a replacement for non-invasive breath sampling procedure with the endoscope. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
10. Evidence of fluid flow in microfractures in geopressured shales
- Author
-
Capuano, R [Univ. of Houston, TX (United States)]
- Published
- 1993
11. Correlation study among 3D-Gait Analysis, Magnetic Resonance Imaging and cognitive parameters in unrestricted people with relapsing-remitting Multiple Sclerosis.
- Author
-
Liparoti, M., Corte, M. Della, Rucco, R., Sparaco, M., Minino, R., Capuano, R., Sorrentino, P., Sorrentino, G., and Bonavita, S.
- Subjects
- *
MAGNETIC resonance imaging , *MAGNETIC resonance , *MULTIPLE sclerosis - Published
- 2018
- Full Text
- View/download PDF
12. Correlation between motor and cognitive parameters, in fully ambulatory relapsing-remitting patients with Multiple Sclerosis: A 3D gait analysis study.
- Author
-
Liparoti, M., Corte, M. Della, Rucco, R., Minino, R., Liccardo, A., Capuano, R., Sorrentino, G., and Bonavita, S.
- Subjects
- *
MULTIPLE sclerosis , *DISEASE relapse , *GAIT in humans , *THIGH muscles , *JOINTS (Anatomy) , *PATIENTS - Published
- 2017
- Full Text
- View/download PDF
13. Clinical applications of volatilomic assays.
- Author
-
Capuano R, Ciotti M, Catini A, Bernardini S, and Di Natale C
- Abstract
The study of metabolomics is revealing immense potential for diagnosis, therapy monitoring, and understanding of pathogenesis processes. Volatilomics is a subcategory of metabolomics interested in the detection of molecules that are small enough to be released in the gas phase. Volatile compounds produced by cellular processes are released into the blood and lymph, and can reach the external environment through different pathways, such as the blood-air interface in the lung that are detected in breath, or the blood-water interface in the kidney that leads to volatile compounds detected in urine. Besides breath and urine, additional sources of volatile compounds such as saliva, blood, feces, and skin are available. Volatilomics traces its roots back over fifty years to the pioneering investigations in the 1970s. Despite extensive research, the field remains in its infancy, hindered by a lack of standardization despite ample experimental evidence. The proliferation of analytical instrumentations, sample preparations and methods of volatilome sampling still make it difficult to compare results from different studies and to establish a common standard approach to volatilomics. This review aims to provide an overview of volatilomics' diagnostic potential, focusing on two key technical aspects: sampling and analysis. Sampling poses a challenge due to the susceptibility of human samples to contamination and confounding factors from various sources like the environment and lifestyle. The discussion then delves into targeted and untargeted approaches in volatilomics. Some case studies are presented to exemplify the results obtained so far. Finally, the review concludes with a discussion on the necessary steps to fully integrate volatilomics into clinical practice.
- Published
- 2024
- Full Text
- View/download PDF
14. Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience.
- Author
-
Novazzi F, Arcari G, Drago Ferrante F, Boutahar S, Genoni AP, Carcione D, Cassani G, Gigante P, Carbotti M, Capuano R, Pasciuta R, and Mancini N
- Abstract
Carbapenem resistance is a serious public health threat, causing numerous deaths annually primarily due to healthcare-associated infections. To face this menace, surveillance programs in high-risk patients are becoming a widespread practice. Here we report the performance of the combined use of a recently approved commercial multiplex real-time PCR assay (REALQUALITY Carba-Screen kit) with conventional phenotypic screening. In this three-month study, 479 rectal swabs from 309 patients across high-risk units were evaluated by combining the two approaches. Although the molecular assay showed a higher positivity rate than phenotypic screening (7.1% vs. 5%), it should be noted that the molecular method alone would have missed eight carbapenem-resistant isolates, while using only phenotypic screening would not have detected sixteen isolates. This demonstrates the complementary strengths of each method. Our study confirms the need for a combined approach to maximize the possible clinical impact of this kind of screening, ensuring a more comprehensive detection of resistant strains.
- Published
- 2024
- Full Text
- View/download PDF
15. Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis.
- Author
-
Andreozzi V, Capuano R, Scannapieco S, Barra F, d'Arco B, Giordano C, Caterino M, De Marca U, Di Filippo F, Di Gregorio M, and Barone P
- Subjects
- Humans, Multiple Sclerosis drug therapy, Multiple Sclerosis, Relapsing-Remitting drug therapy, Bariatric Surgery adverse effects, Dimethyl Fumarate adverse effects, Immunosuppressive Agents adverse effects, Lymphopenia chemically induced
- Abstract
Introduction: Lymphopenia is a known side effect of dimethyl fumarate (DMF), a disease-modifying therapy (DMT) for patients with multiple sclerosis (pwMS). A body mass index ≥ 30 kg/m
2 has been identified as a protective factor; however, no data are available on lymphopenia in pwMS undergoing to weight loss due to bariatric surgery., Methods: We described two pwMS with history of bariatric surgery who started DMF as DMT., Results: The two pwMS experienced persistent lymphopenia during DMF-treatment, which was resolved after its discontinuation., Conclusions: Several mechanisms might modify DMF pharmacokinetic profiles after bariatric surgery and its bioavailability. Absolute lymphocyte count should be monitored in pwMS treated with DMF and history of bariatric surgery and weight loss., (© 2023. Fondazione Società Italiana di Neurologia.)- Published
- 2024
- Full Text
- View/download PDF
16. Nonenzymatic Potentiometric Detection of Ascorbic Acid with Porphyrin/ZnO-Functionalized Laser-Induced Graphene as an Electrode of EGFET Sensors.
- Author
-
Pushparaj K, Catini A, Capuano R, Allegra V, Magna G, Antonelli G, Martinelli E, Agresti A, Pescetelli S, Sivalingam Y, Paolesse R, and Di Natale C
- Abstract
Laser-induced graphene (LIG) has emerged as a highly versatile material with significant potential in the development of electrochemical sensors. In this paper, we investigate the use of LIG and LIG functionalized with ZnO and porphyrins-ZnO as the gate electrodes of the extended gate field effect transistors (EGFETs). The resultant sensors exhibit remarkable sensitivity and selectivity, particularly toward ascorbic acid. The intrinsic sensitivity of LIG undergoes a notable enhancement through the incorporation of hybrid organic-inorganic materials. Among the variations tested, the LIG electrode coated with zinc tetraphenylporphyrin-capped ZnO nanoparticles demonstrates superior performance, reaching a limit of detection of approximately 3 nM. Furthermore, the signal ratio for 5 μM ascorbic acid relative to the same concentration of dopamine exceeds 250. The practical applicability of these sensors is demonstrated through the detection of ascorbic acid in real-world samples, specifically in a commercially available food supplement containing l-arginine. Notably, formulations with added vitamin C exhibit signals at least 25 times larger than those without, underscoring the sensors' capability to discern and quantify the presence of ascorbic acid in complex matrices. This research not only highlights the enhanced performance of LIG-based sensors through functionalization but also underscores their potential for practical applications in the analysis of vitamin-rich supplements., Competing Interests: The authors declare no competing financial interest., (© 2024 The Authors. Published by American Chemical Society.)
- Published
- 2024
- Full Text
- View/download PDF
17. Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study
- Author
-
Vidal-Jordana A, Rovira A, Calderon W, Arrambide G, Castilló J, Moncho D, Rahnama K, Collorone S, Toosy AT, Ciccarelli O, Papadopoulou A, Cerdá-Fuertes N, Lieb JM, Ruggieri S, Tortorella C, Gasperini C, Bisecco A, Capuano R, Gallo A, De Barros A, Salerno A, Auger C, Sastre-Garriga J, Tintore M, and Montalban X
- Subjects
- Humans, Evoked Potentials, Visual, Prospective Studies, Optic Nerve diagnostic imaging, Multiple Sclerosis diagnosis, Multiple Sclerosis diagnostic imaging, Demyelinating Diseases, Optic Neuritis diagnostic imaging
- Abstract
Background and Objectives: The optic nerve is not one of the areas of the CNS that can be used to demonstrate dissemination in space (DIS) within the 2017 McDonald criteria for the diagnosis of multiple sclerosis (MS). Objectives were (1) to assess whether optic nerve-MRI (ON-MRI), optical coherence tomography (OCT), and visual evoked potentials (VEP) detect optic nerve involvement in clinically isolated syndrome (CIS) and (2) to evaluate the contribution of the optic nerve topography to the current diagnostic criteria in a prospective, multicenter cohort., Methods: MAGNIMS centers were invited to provide prospective data on patients with CIS who underwent a visual assessment with at least 2 of 3 investigations (ON-MRI, OCT, or VEP) within 6 months of onset. Modified DIS criteria were constructed by adding the optic nerve topography, defined by each investigation separately and any combination of them, as the fifth area of the CNS. A risk assessment analysis and the performance of the different DIS criteria were analyzed using the diagnosis of MS according to the 2017 McDonald criteria as the primary outcome and new T2 lesions and/or a second relapse as the secondary outcome., Results: We included 157 patients with CIS from 5 MAGNIMS centers; 60/157 (38.2%) patients presented with optic neuritis. Optic nerve involvement on ON-MRI was found in 40.2% patients at study entry and in 72.5% of those with optic neuritis.At follow-up (mean 27.9 months, SD 14.5), 111/157 patients (70.7%) were diagnosed with MS according to the 2017 McDonald criteria. Fulfilling either 2017 DIS or any modified DIS criteria conferred a similar high risk for reaching primary and secondary outcomes. The modified DIS criteria had higher sensitivity (92.5% [with ON-MRI] vs 88.2%), but slightly lower specificity (80.0% [with GCIPL IEA ≥4 μm] vs 82.2%), with overall similar accuracy (86.6% [with ON-MRI] vs 86.5%) than 2017 DIS criteria. Consistent results were found for secondary outcomes., Discussion: In patients with CIS, the presence of an optic nerve lesion defined by MRI, OCT, or VEP is frequently detected, especially when presenting with optic neuritis. Our study supports the addition of the optic nerve as a fifth topography to fulfill DIS criteria.
- Published
- 2024
- Full Text
- View/download PDF
18. Differentiation through E-nose and GC-FID data modeling of rosé sparkling wines elaborated via traditional and Charmat methods.
- Author
-
Muñoz-Castells R, Modesti M, Moreno-García J, Rodríguez-Moreno M, Catini A, Capuano R, Di Natale C, Bellincontro A, and Moreno J
- Abstract
Background: The growing demand for rosé sparkling wine has led to an increase in its production. Traditional or Charmat wine-making influence the aromatic profiles in wine. An analysis such as gas chromatography makes an accurate assessment of wines based on volatile detection but is resource intensive. On the other hand, the electronic nose (E-nose) has emerged as a versatile tool, offering rapid, cost-effective discrimination of wines, and contributing insights into quality and production processes because of its aptitude to perform a global aromatic pattern evaluation. In the present study, rosé sparkling wines were produced using both methods and major volatile compounds and polyols were measured. Wines were tested by E-nose and predictive modelling was performed to distinguish them., Results: Volatile profiles showed differences between Charmat and traditional methods, especially at 5 months of aging. A partial least square discriminant analysis (PLS-DA) was carried out on E-nose detections, obtaining a model that describes 94% of the variability, separating samples in different clusters and correctly identifying different classes. The differences derived from PLS-DA clustering agree with the results obtained by gas-chromatography. Moreover, a principal components regression model was built to verify the ability of the E-nose to non-destructively predict the amount of different volatiles analyzed., Conclusion: Production methods of Rosé sparkling wine affect the final wine aroma profiles as a result of the differences in terms of volatiles. The PLS-DA of the data obtained with E-nose reveals that distinguishing between Charmat and traditional methods is possible. Moreover, predictive models using gas chromatography-flame ionization detection analysis and E-nose highlight the possibility of fast and efficient prediction of volatiles from the E-nose. © 2023 The Authors. Journal of The Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry., (© 2023 The Authors. Journal of The Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.)
- Published
- 2023
- Full Text
- View/download PDF
19. The volatilome signatures of Plasmodium falciparum parasites during the intraerythrocytic development cycle in vitro under exposure to artemisinin drug.
- Author
-
Stead Z, Capuano R, Di Natale C, and Pain A
- Subjects
- Humans, Animals, Plasmodium falciparum, Drug Resistance, Protozoan Proteins pharmacology, Parasites, Antimalarials pharmacology, Antimalarials therapeutic use, Volatile Organic Compounds pharmacology, Artemisinins pharmacology, Artemisinins therapeutic use, Malaria, Falciparum drug therapy, Malaria, Falciparum parasitology, Malaria drug therapy
- Abstract
Volatile organic compounds (VOCs) comprise a diverse range of metabolites with high vapour pressure and low boiling points. Although they have received attention, they are a largely unexplored part of the metabolome. Previous studies have shown that malaria infections produce characteristic, definitive, and detectable volatile signatures. Many transcriptional and metabolic differences are observed at different stages of the parasite Intraerythrocytic Developmental Cycle (IDC) as well as when artemisinin-resistant parasites are put under drug pressure. This prompted our research to characterize whether these responses are reflected at a volatile level in malaria during the IDC stages using gas chromatography-mass spectrometry. We investigated whether the resistant P. falciparum parasites would produce their own characteristic volatilome profile compared to near-isogenic wild-type parasite in vitro; firstly at three different stages of the IDC and secondly in the presence or absence of artemisinin drug treatment. Finally, we explored the VOC profiles from two media environments (Human serum and Albumax) of recently lab-adapted field parasite isolates, from Southeast Asia and West/East Africa, compared to long-term lab-adapted parasites. Recognizable differences were observed between IDC stages, with schizonts having the largest difference between wild type and resistant parasites, and with cyclohexanol and 2,5,5-trimethylheptane only present for resistant schizonts. Artemisinin treatment had little effect on the resistant parasite VOC profile, whilst for the wild type parasites compounds ethylbenzene and nonanal were greatly affected. Lastly, differing culturing conditions had an observable impact on parasite VOC profile and clustering patterns of parasites were specific to geographic origin. The results presented here provide the foundation for future studies on VOC based characterization of P. falciparum strains differing in abilities to tolerate artemisinin., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
20. Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence.
- Author
-
Altieri M, Melisi RD, Conte M, Capuano R, Donnarumma G, Grimaldi E, Coppola N, De Pascalis S, Risi M, d'Ambrosio A, Bisecco A, and Gallo A
- Abstract
Background: Evusheld (EVS) was authorized by FDA and EMA as pre-exposure prophylaxis (PrEP) in people at high risk of severe Covid-19 outcomes, including people with Multiple Sclerosis (pwMS) on B-cell depleting (BCD) therapies-such as Ocrelizumab (OCR). In this population, no data on possible adverse drug reactions (ADRs) to EVS, B-lymphocytes (CD20 +) counts pre- and post-EVS injection, and comparison of percentage increase of IgG antibodies directed against SARS-CoV-2 trimeric spike protein (anti-TSP IgG) post-EVS and Covid-19 vaccine was available. The aim of this study was to better characterize the efficacy and safety profile of EVS in pwMS on BCD agents., Methods: 17 pwMS on OCR agreed to receive EVS as PrEP for Covid-19. Sera samples were collected before the first dose of Covid-19 vaccine (T0), 4 weeks after the second dose (T1), 4 weeks after third dose (T2), immediately before (T3) and 4 weeks after (T4) EVS., Results: Covid-19 vaccine ADRs were mild-to-moderate, whereas no ADRs were reported after EVS injection. A significant increase of anti-TSP IgG was found only at T0-T1 (Z = -3.059, p = .002) and T3-T4 (Z = -3.621, p < .001) time-points. The median percentage increase between T3-T4 was significantly higher with respect to the T0-T1(Z = -3.296, p = .001) and T1-T2 (Z = -3.059, p = .002) time-points., Conclusions: These results further support EVS safety and efficacy in boosting anti-TSP IgG titers in pwMS on OCR, with a statistically greater increase than that observed after completion of a full Covid-19 vaccine cycle, plus a booster dose., (© 2023. Fondazione Società Italiana di Neurologia.)
- Published
- 2023
- Full Text
- View/download PDF
21. Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey.
- Author
-
Altieri M, Capuano R, Bisecco A, d'Ambrosio A, Risi M, Cavalla P, Vercellino M, Annovazzi P, Zaffaroni M, De Stefano N, Stromillo ML, D'Amico E, Zanghì A, Buscarinu MC, Lanzillo R, De Luca G, Calabrese M, Lorefice L, Di Filippo M, Valentino P, Gajofatto A, Marfia GA, Fuiani A, Nociti V, Tedeschi G, and Gallo A
- Subjects
- Humans, Female, Male, Pandemics, Nerve Tissue Proteins, Patient-Centered Care, Quality of Health Care, COVID-19, Multiple Sclerosis epidemiology, Multiple Sclerosis therapy
- Abstract
Background: Covid-19 pandemic impacted on management of people with Multiple Sclerosis (pwMS). Level of satisfaction of pwMS regarding the care received by the staff of Multiple Sclerosis Centers (MSCs) during the pandemic was not fully investigated. In a large patient-centered multicenter study, the therapeutic adherence and quality of care of MSCs was assessed., Methods: In April-May 2021, an online survey was widespread by 16 Italian MSCs. Frequencies, percentages and/or means and standard deviations were calculated to describe the sample. ANOVAs were performed to evaluate the effect of sociodemographic and clinical variables on overall pwMS' rating of MSC assistance., Results: 1670 pwMS completed the survey (67.3% women). During the pandemic, 88% did not change their disease modifying therapy schedule, and 89.1% reached their MSCs with no or little difficulties. Even if only 1.3% of participants underwent a tele-health follow-up visit with their MSC staff, the 80.1% believed that tele-health services should be improved regardless of pandemic. 92% of participants were satisfied of how their MSC took charge of their needs; ANOVAs revealed an effect of disease duration on pwMS' level of satisfaction on MSCs management during the pandemic., Conclusions: The results revealed an efficient MSCs response to Covid-19 pandemic and provided the basis for the implementing of tele-health services that would further improve the taking charge of patients, particularly those with longer disease, higher disability, and/or living far from their MSC., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Antonio Gallo reports a relationship with Biogen that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Antonio Gallo reports a relationship with Merck Serono that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Antonio Gallo reports a relationship with Mylan ITALIA Srl that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Antonio Gallo reports a relationship with Novartis that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Antonio Gallo reports a relationship with Roche that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Antonio Gallo reports a relationship with Sanofi Genzyme that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Antonio Gallo reports a relationship with Teva Health that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Lorena Lorefice reports a relationship with Biogen that includes: consulting or advisory and speaking and lecture fees. Lorena Lorefice reports a relationship with Novartis that includes: consulting or advisory and speaking and lecture fees. Lorena Lorefice reports a relationship with Sanofi that includes: consulting or advisory and speaking and lecture fees. Lorena Lorefice reports a relationship with Sanofi Genzyme that includes: consulting or advisory and speaking and lecture fees. Lorena Lorefice reports a relationship with Merck Serono that includes: consulting or advisory and speaking and lecture fees. Lorena Lorefice reports a relationship with Teva Health that includes: consulting or advisory and speaking and lecture fees. Lorena Lorefice reports a relationship with Almirall Ltd that includes: speaking and lecture fees. Alvino Bisecco reports a relationship with Biogen that includes: consulting or advisory and speaking and lecture fees. Alvino Bisecco reports a relationship with Roche that includes: consulting or advisory and speaking and lecture fees. Alvino Bisecco reports a relationship with Merck & Co Inc that includes: consulting or advisory and speaking and lecture fees. Alvino Bisecco reports a relationship with Celgene Corp Los Angeles that includes: consulting or advisory and speaking and lecture fees. Alvino Bisecco reports a relationship with Sanofi Genzyme that includes: consulting or advisory and speaking and lecture fees. Massimiliano Calabrese reports a relationship with Biogen that includes: speaking and lecture fees. Massimiliano Calabrese reports a relationship with Bristol Myers Squibb that includes: speaking and lecture fees. Massimiliano Calabrese reports a relationship with Celgene Corp Los Angeles that includes: speaking and lecture fees. Massimiliano Calabrese reports a relationship with Sanofi Genzyme that includes: speaking and lecture fees. Massimiliano Calabrese reports a relationship with Merck Serono that includes: speaking and lecture fees. Massimiliano Calabrese reports a relationship with Novartis that includes: speaking and lecture fees. Massimiliano Calabrese reports a relationship with Roche that includes: speaking and lecture fees. Massimiliano Calabrese reports a relationship with International Progressive MS Alliance that includes: funding grants. Massimiliano Calabrese reports a relationship with Ministry of Health that includes: funding grants. Massimiliano Di Filippo reports a relationship with Bayer AG that includes: speaking and lecture fees and travel reimbursement. Massimiliano Di Filippo reports a relationship with Biogen Italy that includes: speaking and lecture fees and travel reimbursement. Massimiliano Di Filippo reports a relationship with Sanofi Genzyme that includes: speaking and lecture fees and travel reimbursement. Massimiliano Di Filippo reports a relationship with Merck & Co Inc that includes: speaking and lecture fees and travel reimbursement. Massimiliano Di Filippo reports a relationship with Mylan ITALIA Srl that includes: speaking and lecture fees and travel reimbursement. Massimiliano Di Filippo reports a relationship with Novartis that includes: speaking and lecture fees and travel reimbursement. Massimiliano Di Filippo reports a relationship with Roche that includes: speaking and lecture fees and travel reimbursement. Massimiliano Di Filippo reports a relationship with Siemens Healthineers that includes: speaking and lecture fees and travel reimbursement. Massimiliano Di Filippo reports a relationship with Teva Health that includes: speaking and lecture fees and travel reimbursement. Gioacchino Tedeschi reports a relationship with Teva Health that includes: board membership. Gioacchino Tedeschi reports a relationship with Roche that includes: board membership. Gioacchino Tedeschi reports a relationship with Eli Lilly Italy that includes: board membership. Gioacchino Tedeschi reports a relationship with Allergan US that includes: board membership. Gioacchino Tedeschi reports a relationship with Sanofi-Aventis US LLC that includes: speaking and lecture fees and travel reimbursement. Gioacchino Tedeschi reports a relationship with Merck Serono Ltd that includes: speaking and lecture fees and travel reimbursement. Gioacchino Tedeschi reports a relationship with Bayer Schering Pharma AG that includes: speaking and lecture fees and travel reimbursement. Gioacchino Tedeschi reports a relationship with Biogen Italy that includes: speaking and lecture fees and travel reimbursement. Gioacchino Tedeschi reports a relationship with Novartis that includes: speaking and lecture fees and travel reimbursement., (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
22. Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
- Author
-
Capuano R, Prosperini L, Altieri M, Lorefice L, Fantozzi R, Cavalla P, Guaschino C, Radaelli M, Cordioli C, Nociti V, Boffa L, Ragonese P, Di Gregorio M, Pinardi F, Torri Clerici V, De Luca G, Gajofatto A, Paolicelli D, Tortorella C, Gasperini C, Solaro C, Cocco E, Bisecco A, and Gallo A
- Subjects
- Humans, COVID-19 Vaccines, SARS-CoV-2, Natalizumab therapeutic use, Fingolimod Hydrochloride, RNA, Messenger, mRNA Vaccines, Multiple Sclerosis drug therapy, COVID-19 prevention & control
- Abstract
Background: Little is known about COVID-19 course and outcomes after a third booster dose of mRNA vaccine against SARS-CoV-2 (mRNA-Vax) in patients with multiple sclerosis (pwMS) treated with ocrelizumab (OCR) and fingolimod (FNG), which showed a weakened immune response to mRNA-vax., Objectives: The aim of this study was to evaluate COVID-19 course and outcomes in pwMS on OCR and FNG after receiving the third dose of mRNA-Vax and to compare it with pwMS on natalizumab (NTZ)., Methods: Inclusion criteria: >18 years of age, being treated with OCR/FNG/NTZ since the first mRNA-Vax dose; COVID-19 after a third booster dose of mRNA-Vax; no steroids use., Results: Overall, 290 pwMS (79 NTZ, 126 OCR, and 85 FNG) from 17 Italian MS centers were included. Age, Expanded Disability Status Scale (EDSS) score, MS phenotype, disease, and treatment duration were significantly different across groups. PwMS who had COVID-19 on OCR and FNG compared with those on NTZ were slightly more symptomatic with higher hospitalization rates (11.1% vs 7.1% vs 1.3%, respectively). Regression models showed that the majority of the differences observed were not related to the disease-modifying treatments (DMTs) used. No fatal cases were observed., Conclusion: Our results support the effectiveness of the third booster dose of mRNA-Vax against severe forms of COVID-19 in pwMS treated with OCR and FNG.
- Published
- 2023
- Full Text
- View/download PDF
23. On-Field Test of Tuberculosis Diagnosis through Exhaled Breath Analysis with a Gas Sensor Array.
- Author
-
Ketchanji Mougang YC, Endale Mangamba LM, Capuano R, Ciccacci F, Catini A, Paolesse R, Mbatchou Ngahane HB, Palombi L, and Di Natale C
- Subjects
- Humans, Breath Tests methods, Microscopy, Nucleic Acid Amplification Techniques methods, Exhalation, Sensitivity and Specificity, Tuberculosis diagnosis, Tuberculosis, Pulmonary diagnosis
- Abstract
Tuberculosis (TB) is among the more frequent causes of death in many countries. For pulmonary TB, early diagnosis greatly increases the efficiency of therapies. Although highly sensitive tests based on nucleic acid amplification tests (NAATs) and loop-mediated isothermal amplification (TB-LAMP) are available, smear microscopy is still the most widespread diagnostics method in most low-middle-income countries, and the true positive rate of smear microscopy is lower than 65%. Thus, there is a need to increase the performance of low-cost diagnosis. For many years, the use of sensors to analyze the exhaled volatile organic compounds (VOCs) has been proposed as a promising alternative for the diagnosis of several diseases, including tuberculosis. In this paper, the diagnostic properties of an electronic nose (EN) based on sensor technology previously used to identify tuberculosis have been tested on-field in a Cameroon hospital. The EN analyzed the breath of a cohort of subjects including pulmonary TB patients (46), healthy controls (38), and TB suspects (16). Machine learning analysis of the sensor array data allows for the identification of the pulmonary TB group with respect to healthy controls with 88% accuracy, 90.8% sensitivity, 85.7% specificity, and 0.88 AUC. The model trained with TB and healthy controls maintains its performance when it is applied to symptomatic TB suspects with a negative TB-LAMP. These results encourage the investigation of electronic noses as an effective diagnostic method for future inclusion in clinical practice.
- Published
- 2023
- Full Text
- View/download PDF
24. Poly(lactic acid)/Plasticizer/Nano-Silica Ternary Systems: Properties Evolution and Effects on Degradation Rate.
- Author
-
Capuano R, Avolio R, Castaldo R, Cocca M, Dal Poggetto G, Gentile G, and Errico ME
- Abstract
Plasticized nanocomposites based on poly(lactic acid) have been prepared by melt mixing following a two-step approach, adding two different oligomeric esters of lactic acid (OLAs) as plasticizers and fumed silica nanoparticles. The nanocomposites maintained a remarkable elongation at break in the presence of the nanoparticles, with no strong effects on modulus and strength. Measuring thermo-mechanical properties as a function of aging time revealed a progressive deterioration of properties, with the buildup of phase separation, related to the nature of the plasticizer. Materials containing hydroxyl-terminated OLA showed a higher stability of properties upon aging. On the contrary, a synergistic effect of the acid-terminated plasticizer and silica nanoparticles was pointed out, inducing an accelerated hydrolytic degradation of PLA: materials at high silica content exhibited a marked brittleness and a dramatic decrease of molecular weight after 16 weeks of aging.
- Published
- 2023
- Full Text
- View/download PDF
25. Personal VOCs Exposure with a Sensor Network Based on Low-Cost Gas Sensor, and Machine Learning Enabled Indoor Localization.
- Author
-
Papale L, Catini A, Capuano R, Allegra V, Martinelli E, Palmacci M, Tranfo G, and Di Natale C
- Abstract
Indoor locations with limited air exchange can easily be contaminated by harmful volatile compounds. Thus, is of great interest to monitor the distribution of chemicals indoors to reduce associated risks. To this end, we introduce a monitoring system based on a Machine Learning approach that processes the information delivered by a low-cost wearable VOC sensor incorporated in a Wireless Sensor Network (WSN). The WSN includes fixed anchor nodes necessary for the localization of mobile devices. The localization of mobile sensor units is the main challenge for indoor applications. Yes. The localization of mobile devices was performed by analyzing the RSSIs with machine learning algorithms aimed at localizing the emitting source in a predefined map. Tests performed on a 120 m
2 meandered indoor location showed a localization accuracy greater than 99%. The WSN, equipped with a commercial metal oxide semiconductor gas sensor, was used to map the distribution of ethanol from a point-like source. The sensor signal correlated with the actual ethanol concentration as measured by a PhotoIonization Detector (PID), demonstrating the simultaneous detection and localization of the VOC source.- Published
- 2023
- Full Text
- View/download PDF
26. A Pilot Study for Legionella pneumophila Volatilome Characterization Using a Gas Sensor Array and GC/MS Techniques.
- Author
-
Capuano R, Mansi A, Paba E, Marcelloni AM, Chiominto A, Proietto AR, Gordiani A, Catini A, Paolesse R, Tranfo G, and Di Natale C
- Subjects
- Humans, Pilot Projects, Gas Chromatography-Mass Spectrometry, Legionella pneumophila, Legionnaires' Disease diagnosis, Legionnaires' Disease microbiology, Legionella
- Abstract
Legionellosis is a generic term describing the pneumonic (Legionnaires' disease, LD) and non-pneumonic (Pontiac fever, PF) forms of infection with bacteria belonging to the genus Legionella . Currently, the techniques used to detect Legionella spp. in water samples have certain limitations and drawbacks, and thus, there is a need to identify new tools to carry out low-cost and rapid analysis. In this regard, several studies demonstrated that a volatolomics approach rapidly detects and discriminates different species of microorganisms via their volatile signature. In this paper, the volatile organic compounds (VOCs) pattern emitted in vitro by Legionella pneumophila cultures is characterized and compared to those produced by other Legionella species and by Pseudomonas aeruginosa , using a gas sensor array and gas chromatograph mass spectrometer (GC-MS). Bacterial cultures were measured at the 3rd and 7th day after the incubation. Sensor array data analyzed via the K-nearest neighbours (k-NN) algorithm showed a sensitivity to Legionella pneumophila identification at around 89%. On the other hand, GC-MS identified a bouquet of VOCs, mainly alcohols and ketones, that enable the differentiation of Legionella pneumophila in respect to other waterborne microorganisms., Competing Interests: The authors declare no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
27. Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod.
- Author
-
Capuano R, Altieri M, Conte M, Bisecco A, d'Ambrosio A, Donnarumma G, Grimaldi E, Coppola N, Medici N, Galdiero M, Tedeschi G, and Gallo A
- Subjects
- Humans, Fingolimod Hydrochloride adverse effects, BNT162 Vaccine, COVID-19 Vaccines adverse effects, RNA, Messenger, SARS-CoV-2, Immunoglobulin G, Antibodies, Viral, mRNA Vaccines, Multiple Sclerosis drug therapy, COVID-19 prevention & control
- Abstract
Background: The assessment of the safety and the humoral response to a third booster dose of the BNT162b2 mRNA COVID-19 vaccine is relevant in patients with Multiple Sclerosis (pwMS) treated with Ocrelizumab (OCR) or Fingolimod (FNG)., Methods: Serum samples were collected from Healthy controls (HCs) and pwMS treated with OCR or FNG at the following time-points: before the first of two vaccine doses (T0); 8 (T1), 16 (T2), 24 (T3) weeks after the first dose; within 8 weeks before (T0b) and after (T1b) the booster dose. IgG antibodies to SARS-CoV-2 trimeric spike protein (Anti-TSP IgG) were quantified and expressed as binding antibody units (BAU)/mL., Results: 40 HCs, 28 pwMS on OCR and 19 on FNG were included. At T0b 12 (42.9%) pwMS on OCR and 6 (31.6%) on FNG were still positive while, at T1b 16 (57.14%) pwMS on OCR and 16 (84.2%) on FNG, passed the threshold of positivity. The increase of Anti-TSP IgG levels at T1b was higher for: (i) HCs with respect to OCR (p < 0.001) and FNG (p = 0.032) groups; (ii) pwMS on FNG compared with pwMS on OCR (p < 0.001). No socio-demographic, clinical or laboratory variables were able to predict the anti-TSP IgG increase between T0b and T1b. Neither clinical relapses nor severe adverse events were reported in pwMS after each dose of vaccine., Conclusions: The third booster dose of BNT162b2 mRNA vaccine to OCR- and FNG-treated pwMS revives the humoral response, independently of any clinical variable, and manifests a good safety and tolerability profile., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
28. Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents.
- Author
-
Gentili L, Capuano R, Gaetani L, Fiacca A, Bisecco A, d'Ambrosio A, Mancini A, Guercini G, Tedeschi G, Parnetti L, Gallo A, and Di Filippo M
- Subjects
- Humans, Gadolinium, Magnetic Resonance Imaging, Brain diagnostic imaging, Contrast Media, Multiple Sclerosis diagnostic imaging
- Published
- 2022
- Full Text
- View/download PDF
29. Impact of post-contrast MRI in the definition of active multiple sclerosis.
- Author
-
Gentili L, Capuano R, Gaetani L, Fiacca A, Bisecco A, d'Ambrosio A, Mancini A, Guercini G, Tedeschi G, Parnetti L, Gallo A, and Di Filippo M
- Subjects
- Brain diagnostic imaging, Brain pathology, Gadolinium, Humans, Magnetic Resonance Imaging methods, Retrospective Studies, Multiple Sclerosis diagnostic imaging, Multiple Sclerosis pathology, Multiple Sclerosis, Relapsing-Remitting diagnostic imaging, Multiple Sclerosis, Relapsing-Remitting pathology
- Abstract
Background: For multiple sclerosis (MS) phenotypes classification, the presence of "disease activity" can be defined by clinical relapses and/or by magnetic resonance imaging (MRI) through gadolinium-enhancing (Gd+) lesions or new/enlarged T2 lesions. Recent MRI and pathology findings have demonstrated Gd deposition in the brain, suggesting to avoid Gd administration when dispensable. In this scenario, we aimed to evaluate the contribution of post-contrast MRIs to the definition of "active" MS phenotype., Methods: We retrospectively selected 84 "active" relapsing-remitting MS (RRMS) patients according to Lublin 2013, calculating both the number of Gd+ lesions not detectable as new/unequivocally enlarged on T2 images and the proportion of patients who would be still correctly classified as "active" without Gd administration., Results: 13 out of 164 (7.9%) Gd+ lesions did not correspond to a new/enlarged T2 lesion. Gd administration did not modify the classification of MS as "active" in 83 out of 84 subjects (98.8%)., Conclusion: The contribution of Gd+ lesions to the correct classification of RRMS patients as "active" is marginal, thus limiting the need of routine Gd administration for this scope. Further studies are warranted to support these conclusions., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
30. Volatolomic urinary profile analysis for diagnosis of the early stage of lung cancer.
- Author
-
Gasparri R, Capuano R, Guaglio A, Caminiti V, Canini F, Catini A, Sedda G, Paolesse R, Di Natale C, and Spaggiari L
- Subjects
- Biomarkers analysis, Breath Tests methods, Early Detection of Cancer, Electronic Nose, Humans, Prospective Studies, Lung Neoplasms diagnosis, Volatile Organic Compounds analysis
- Abstract
Currently, in clinical practice there is a pressing need for potential biomarkers that can identify lung cancer at early stage before becoming symptomatic or detectable by conventional means. Several researchers have independently pointed out that the volatile organic compounds (VOCs) profile can be considered as a lung cancer fingerprint useful for diagnosis. In particular, 16% of volatiles contributing to the human volatilome are found in urine, which is therefore an ideal sample medium. Its analysis through non-invasive, relatively low-cost and straightforward techniques could offer great potential for the early diagnosis of lung cancer. In this study, urinary VOCs were analysed with a gas chromatography-ion mobility spectrometer (GC-IMS) and an electronic nose (e-nose) made by a matrix of twelve quartz microbalances complemented by a photoionization detector. This clinical prospective study involved 127 individuals, divided into two groups: 46 with lung cancer stage I-II-III confirmed by computerized tomography or positron emission tomography-imaging techniques and histology (biopsy), and 81 healthy controls. Both instruments provided a multivariate signal which, after being analysed by a machine learning algorithm, identified eight VOCs that could distinguish lung cancer patients from healthy ones. The eight VOCs are 2-pentanone, 2-hexenal, 2-hexen-1-ol, hept-4-en-2-ol, 2-heptanone, 3-octen-2-one, 4-methylpentanol, 4-methyl-octane. Results show that GC-IMS identifies lung cancer with respect to the control group with a diagnostic accuracy of 88%. Sensitivity resulted as being 85%, and specificity was 90%-Area Under the Receiver Operating Characteristics: 0.91. The contribution made by the e-nose was also important, even though the results were slightly less sensitive with an accuracy of 71.6%. Moreover, of the eight VOCs identified as potential biomarkers, five VOCs had a high sensitivity ( p ⩽ 0.06) for early stage (stage I) lung cancer., (© 2022 IOP Publishing Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
31. Monitoring Fish Freshness in Real Time under Realistic Conditions through a Single Metal Oxide Gas Sensor.
- Author
-
Zambotti G, Capuano R, Pasqualetti V, Soprani M, Gobbi E, Di Natale C, and Ponzoni A
- Subjects
- Animals, Bacteria, Gas Chromatography-Mass Spectrometry, Oxides, Temperature, Sea Bream
- Abstract
The realization of an unobtrusive and effective technology able to track fish freshness in real time and inform on its edibility is highly demanded, but still unachieved. In the present paper, we address this issue through a single metal oxide gas sensor working in temperature modulation mode. The system can work without an external reference air source, which is an appealing feature for its possible integration in domestic refrigerators. Tests were carried out using fresh sea bream fillets as case study and working both inside the refrigerator and at room temperature. Parallel gas chromatography-mass spectrometry and microbiological characterization indicated the marked dependence of both the microbiological condition and the gas-phase composition from the individual sample and from the storage temperature. Despite such a large variability, which may be expected in real applications, the proposed system provided similar responses whenever the total bacterial population approached and exceeded the edibility threshold of 10
7 CFU/g.- Published
- 2022
- Full Text
- View/download PDF
32. The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis.
- Author
-
Altieri M, Capuano R, Bisecco A, d'Ambrosio A, Buonanno D, Tedeschi G, Santangelo G, and Gallo A
- Subjects
- Anxiety epidemiology, Cross-Sectional Studies, Depression epidemiology, Depression etiology, Humans, Pandemics, Quality of Life, SARS-CoV-2, Stress, Psychological epidemiology, COVID-19 epidemiology, Multiple Sclerosis complications, Multiple Sclerosis epidemiology, Sleep Wake Disorders epidemiology, Sleep Wake Disorders etiology
- Abstract
Background: Covid-19 pandemic caused relevant psychological consequences in the general population. Since people with Multiple Sclerosis (pwMS) are usually at higher risk of psychological distress than age-matched healthy controls (HC), a meta-analytic study was conducted, aimed at evaluating i) differences between pwMS and HC in the psychological variables during the pandemic, ii) differences in the levels of anxiety, depression, stress, sleep disturbances and quality of life before and during the Covid-19 pandemic in pwMS., Methods: The literature search on three electronic databases yielded 196 studies (113 after the duplicates removal). Seven studies compared psychological variables between pwMS and HC during the pandemic, while seven studies evaluated the pre- vs during the pandemic differences in pwMS. The following outcomes were selected: depression, anxiety, physical QoL, mental QoL, stress, sleep quality/disturbances. Mean weighted effect sizes (ES) were calculated using Hedges'g, via Prometa3 software., Results: During the pandemic, pwMS showed higher levels of depression (g = 0.51, p=.001), anxiety (g = 0.41, p=.032), and stress (g = 0.51, p=.016) compared to HC. The comparison on psychological outcomes before and during the pandemic in pwMS revealed no significant increase during the pandemic on levels of anxiety (g = 0.08, p=.380), depression (g = 0.02, p=.772), mental QoL (g= -0.14, p=.060), physical QoL (g = 0.00, p=.986), whereas sleep quality deteriorated during the pandemic (g = 0.52, p<.001)., Conclusions: In agreement with pre-pandemic literature, pwMS showed higher levels of psychological distress than HC also during the Covid-19 pandemic. Contrariwise, longitudinal studies revealed that, in pwMS, the only psychological-associated variable that worsened significantly was the sleep quality, but this outcome was evaluated only in two studies. Future studies will have to assess/evaluate the long-term psychological consequences of the pandemic on pwMS., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
33. Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab.
- Author
-
Altieri M, Capuano R, Conte M, Donnarumma G, Grimaldi E, Coppola N, Galdiero M, d'Ambrosio A, Tedeschi G, and Gallo A
- Subjects
- Antibodies, Viral, BNT162 Vaccine, COVID-19 Vaccines therapeutic use, Humans, Immunoglobulin G, Natalizumab therapeutic use, RNA, Messenger, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Vaccines, Synthetic, mRNA Vaccines, COVID-19 prevention & control, Multiple Sclerosis drug therapy
- Abstract
Background: Few studies investigated the immune response to SARS-CoV-2 vaccine in patients with multiple sclerosis (pwMS) treated with natalizumab (NTZ) and found a short-term efficient humoral response; however, there are no studies assessing the levels of SARS-CoV-2 IgG antibodies in pwMS treated with NTZ over time., Methods: Humoral immune response to BNT162b2 mRNA COVID-19 vaccine was assessed in a group of 26 pwMS on NTZ up to 6 months after a full COVID-19 vaccination cycle and compared it with 43 age- and sex-matched group of HC. Serum samples were collected before the first dose (T0), and 4 weeks (T1) and 6 months (T2) after the first dose of BNT162b2 mRNA COVID-19 vaccine. The LIAISON® SARS-CoV-2 TrimericS-IgG assay (DiaSorin-S.p.A.) was employed for the detection of IgG antibodies to SARS-CoV-2 spike protein (cutoff for positive IgG antibodies: 33.8 BAU/mL)., Results: At T1 and T2, both groups showed an efficient humoral response to BNT162b2 mRNA COVID-19 vaccine. A significant reduction of IgG antibodies to SARS-CoV-2 spike protein was detected at T2 both in pwMS and in HC, but SARS-CoV-2 IgG antibodies were still above the cutoff limit in all participants., Conclusions: pwMS on NTZ develop and maintain a long-term humoral response after a full COVID-19 vaccination cycle comparable to their healthy peers, and these findings are relevant for clinicians called to counsel about COVID-19 mRNA vaccine timing and booster doses in pwMS treated with NTZ., (© 2022. Fondazione Società Italiana di Neurologia.)
- Published
- 2022
- Full Text
- View/download PDF
34. Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod.
- Author
-
Capuano R, Bisecco A, Conte M, Donnarumma G, Altieri M, Grimaldi E, Franci G, Chianese A, Galdiero M, Coppola N, Tedeschi G, and Gallo A
- Subjects
- Antibodies, Monoclonal, Humanized, Antibodies, Viral, BNT162 Vaccine, COVID-19 Vaccines, Fingolimod Hydrochloride therapeutic use, Humans, Immunoglobulin G therapeutic use, RNA, Messenger, SARS-CoV-2, Vaccination, Vaccines, Synthetic, mRNA Vaccines, COVID-19 prevention & control, Multiple Sclerosis drug therapy
- Abstract
Introduction: Real-world clinical data suggest an attenuated short-term humoral response to SARS-CoV-2 vaccines in patients with multiple sclerosis (pwMS) receiving high efficacy (HE) disease modifying therapies (DMTs) such as Ocrelizumab (OCR) and Fingolimod (FNG). Long-term humoral response in pwMS treated with these HE-DMTs has been poorly investigated. The aim of our study was to explore: i) the humoral response up to six months after a full cycle of the BNT162b2 mRNA Covid-19 vaccine in pwMS treated with OCR and FNG and to compare it to age- and sex-matched healthy controls (HCs); ii) the relationship between humoral response and clinical and immunological characteristics of the studied population., Methods: Serum samples were collected from HCs and pwMS treated with OCR or FNG at the following time points: before BNT162b2 mRNA Covid-19 vaccine (T0), and 4 (T1), 8 (T2), 16 (T3) and 24 (T4) weeks after the first dose. Sera were stored at -20 °C and tested for the quantitative detection of IgG antibodies to SARS-CoV-2 trimeric spike protein (Anti-TSP IgG) expressed in binding antibody units (BAU). At T1 neutralizing antibodies (NAbs) titres were assessed. The relationship between Anti-TSP IgG at each time-point and clinical and laboratoristic analyses were analysed by the Spearman correlation coefficient., Results: 47 HCs and 50 pwMS (28 on OCR and 22 on FNG) were included in the study. All HCs mounted a positive humoral response at T1 and preserved it up to six months. At T1 only 57.1% pwMS on OCR (p < 0.001 compared with HCs) and 40.9% on FNG (p < 0.001) had a positive humoral response at T1, with only 39.3% and 27.3% maintaining a positive response at sixth months (T4), respectively. A strong positive correlation was observed between Nabs titres and Anti-TSP IgG at T1 (rho 0.87, p < 0.0001) with NAbs titres significantly higher in HCs compared with pwMS on OCR and FNG (p<0.0001). We also found a strong positive correlation between time-window since last OCR infusion and anti-TSP IgG titres at all time-points (T1 rho=0.58, p = 0.001; T2 rho=0.59, p = 0.001; T3 rho=0.53, p = 0.004; T4 rho=0.47, p = 0.01). In the FNG group we observed a significant correlation between the humoral response measured from T1 to T4 and: i) treatment duration (T1: rho -0.65, p = 0.001; T2: rho -0.8 p< 0.001; T3: rho -0.72, p=<0.001; T4: rho -0.67, p<0.001), ii) disease duration (T1: rho -0.5, p = 0.017; T2: rho -0.6, p = 0.003; T3: rho -0.58, p = 0.005; T4: rho -0.57, p = 0.006), and iii) baseline total lymphocyte count (T1: rho 0.37, p = 0.08; T2: rho 0.45, p = 0.03; T3: rho 0.43, p = 0.04; T4: rho 0.45, p = 0.03)., Conclusions: Our long-term data show a weakened and short-lasting humoral response to SARS-CoV-2 mRNA vaccine in pwMS treated with OCR and FNG when compared with HCs. MS neurologists should take into account the time elapsed since the last infusion for pwMS on OCR, and the lymphocyte count as well as the disease and treatment duration for those on FNG when called to counsel such pwMS regarding the vaccination with the SARS-CoV-2 mRNA vaccine., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
35. Sustainable Cellulose-Aluminum-Plastic Composites from Beverage Cartons Scraps and Recycled Polyethylene.
- Author
-
Bonadies I, Capuano R, Avolio R, Castaldo R, Cocca M, Gentile G, and Errico ME
- Abstract
The sustainable management of multilayer paper/plastic waste is a technological challenge due to its composite nature. In this paper, a mechanical recycling approach for multilayer cartons (MC) is reported, illustrating the realization of thermoplastic composites based on recycled polyethylene and an amount of milled MC ranging from 20 to 90 wt%. The effect of composition of the composites on the morphology and on thermal, mechanical, and water absorption behavior was investigated and rationalized, demonstrating that above 80 wt% of MC, the fibrous nature of the filler dominates the overall properties of the materials. A maleated polyethylene was also used as a coupling agent and its effectiveness in improving mechanical parameters of composites up to 60 wt% of MC was highlighted.
- Published
- 2022
- Full Text
- View/download PDF
36. A Lab-on-a-Chip Based Automatic Platform for Continuous Nitrites Sensing in Aquaculture.
- Author
-
Catini A, Capuano R, Tancredi G, Dionisi G, Di Giuseppe D, Filippi J, Martinelli E, and Di Natale C
- Subjects
- Animals, Aquaculture, Colorimetry, Lab-On-A-Chip Devices, Nitrites analysis, Water Pollutants, Chemical analysis
- Abstract
In aquaculture, the density of fish stock, use of feeding, and surrounding environmental conditions can easily result in an excessive concentration of harmful compounds that require continuous monitoring. Chemical sensors are available for most of these compounds, however, operative conditions and continuous monitoring in water make the development of sensors suitable for long and unattended deployments difficult. A possible solution is the development of engineered automatic labs where the uptake of sample and the contact with water is reduced and the use of a minimal quantity of reagents enables the implementation of reliable chemical assays. In this paper, a platform for automatic chemical assays is presented. The concept is demonstrated with the detection of nitrites based on the well-known colorimetric Griess reaction. The platform is centered around a lab-on-a-chip where reagents and water samples are mixed. The color of the reaction product is measured with low-cost optoelectronic components. Results show the feasibility of the approach with a minimum detectable concentration of about 0.1 mg/L which is below the tolerance level for aquaculture farms.
- Published
- 2022
- Full Text
- View/download PDF
37. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy.
- Author
-
Baj A, Novazzi F, Ferrante FD, Genoni A, Cassani G, Prestia M, Colombo A, Capuano R, Zago C, Pasciuta R, Tamborini A, Rossi A, Tettamanzi E, Catanoso G, Focosi D, Maffioli L, and Maggi F
- Subjects
- Antibodies, Monoclonal, Humanized immunology, Antibodies, Monoclonal, Humanized pharmacology, Female, Genome, Viral genetics, Humans, Italy, Middle Aged, Peru, Severe Acute Respiratory Syndrome pathology, Severe Acute Respiratory Syndrome virology, World Health Organization, COVID-19 pathology, SARS-CoV-2 drug effects, SARS-CoV-2 genetics, SARS-CoV-2 isolation & purification, Thyroiditis, Autoimmune pathology
- Published
- 2021
- Full Text
- View/download PDF
38. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.
- Author
-
Baj A, Novazzi F, Genoni A, Ferrante FD, Taborelli S, Pini B, Partenope M, Valli M, Gasperina DD, Capuano R, Prestia M, Spezia PG, Azzi L, Focosi D, and Maggi F
- Subjects
- Adult, BNT162 Vaccine, COVID-19 virology, Female, Health Personnel, Humans, Italy, Male, Middle Aged, Nasopharynx virology, SARS-CoV-2 genetics, COVID-19 prevention & control, COVID-19 Vaccines immunology, SARS-CoV-2 immunology, Spike Glycoprotein, Coronavirus genetics, Vaccination
- Abstract
We report 11 cases of SARS-CoV-2 infection in healthcare workers (HCW) naïve for COVID-19 and seropositive after the second dose of the BNT162b2 mRNA vaccine. Based on voluntary-based surveillance, they tested positive for different strains of SARS-CoV-2, as Spike gene sequencing showed. Five of them reported mild symptoms. Given the risk for SARS-CoV-2 introduction from asymptomatic vaccinees, this case series suggests the need to continue nasopharyngeal screening programmes.
- Published
- 2021
- Full Text
- View/download PDF
39. Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy.
- Author
-
Novazzi F, Genoni A, Spezia PG, Focosi D, Zago C, Colombo A, Cassani G, Pasciuta R, Tamborini A, Rossi A, Prestia M, Capuano R, Gasperina DD, Dentali F, Severgnini P, Ageno W, Gambarini C, Stefanelli P, Baj A, and Maggi F
- Subjects
- Aged, Humans, Italy, Malawi, Male, Phylogeny, SARS-CoV-2 classification, SARS-CoV-2 genetics, SARS-CoV-2 physiology, Travel, COVID-19 virology, SARS-CoV-2 isolation & purification
- Abstract
We report here an imported case of SARS-CoV-2 variant of concern B.1.1.351 (also known as 20H/501Y.V2 or "South African variant" or VOC 202012/02) in a 66-years old symptomatic male who returned from Malawi to Italy.
- Published
- 2021
- Full Text
- View/download PDF
40. The Burden of Cardio-Cerebrovascular Risk Factors: Differences Between Individual Risk and Population Risk.
- Author
-
Capuano E, Marchese F, Capuano R, Piramide N, Palumbo R, Simonis V, Iannone AG, Pironti S, and Capuano V
- Subjects
- Humans, Risk Factors, Cardiovascular Diseases epidemiology, Cerebrovascular Disorders epidemiology
- Abstract
Introduction: Cardio-cerebrovascular (CCV) disease contributes significantly to the global burden of disease, with dramatic consequences in terms of mortality and general health. Mitigate CCV risk factors is the key to reduce individual and population risk of CCV events. Evidence-based medicine and epidemiological investigations of risk factors are essential to optimize actions., Aim: To contribute to the knowledge of the burden of risk factors in determining CCV events in the individual patient and in the community., Methods: Clinical data and risk factors were collected through a longitudinal survey (1999) as part of a larger epidemiology and cardiovascular prevention project, namely the "VIP (Valle dell'Irno Prevention) Project". We assessed the incidence of major cardiovascular events (MACE) and for each risk factor we calculated: prevalence, absolute risk, odds ratio (OR), additional risk (AR) = risk of exposed to the risk factor - risk of non-exposed, population attributable risk (PAR) = additional risk * prevalence, population attributable risk fraction (PAF) = PAR/total incidence of the disease., Results: Comparing the MACE group with the non-MACE group, a statistically significant difference was found for the following: glomerular filtration rate (GFR), glucose and systolic blood pressure (SBP), BMI, diastolic blood pressure (DBP), cholesterol, triglycerides, creatinine and uric acid. GFR, glucose and SBP showed the highest OR. Age, creatinine, glycemia, SBP and uric acid were independent predictor of MACE. When calculating the PAF, the CCV risk factors with the greatest impact on MACE were: SBP (29.6%), triglyceridemia (19.4%) and metabolic syndrome (18.3%)., Conclusion: The burden of risk factors on MACE changes substantially according to whether it is calculated in the single patient or in the population. It is crucial for physicians to take these differences into account when applying their own intervention to reduce CCV events., (© 2021. Italian Society of Hypertension.)
- Published
- 2021
- Full Text
- View/download PDF
41. Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability.
- Author
-
Capuano R, Zubizarreta I, Alba-Arbalat S, Sepulveda M, Sola-Valls N, Pulido-Valdeolivas I, Andorra M, Martinez-Heras E, Solana E, Lopez-Soley E, Montejo C, Blanco Y, Fernández-Velasco JI, Gallo A, Bisecco A, Villoslada P, Saiz A, Llufriu S, Villar LM, and Martinez-Lapiscina EH
- Subjects
- Blindness, Child, Female, Humans, Recurrence, Retina, Multiple Sclerosis, Oligoclonal Bands
- Abstract
Background: Prognostic markers are needed to guide multiple sclerosis (MS) management in the context of large availability of disease-modifying drugs (DMDs)., Objective: To investigate the role of cerebrospinal fluid (CSF) markers to inform long-term MS outcomes., Methods: Demographic features, IgM index, oligoclonal IgM bands (OCMB), lipid-specific OCMB, CSF neurofilament light chain protein levels, expanded disability status scale (EDSS), relapses and DMD use over the study period and peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell plus inner plexiform layer (GCIPL) thicknesses in non-optic neuritis eyes (end of follow-up) were collected from relapsing MS (RMS) patients with CSF obtained ⩽2 years after MS onset prospectively followed at the Hospital Clinic of Barcelona. We assessed associations between CSF markers and MS outcomes using multivariable models., Results: A total of 89 patients (71 females; median 32.9 years of age) followed over a median of 9.6 years were included. OCMB were associated with a 33% increase in the annualized relapse rate (ARR; p = 0.06), higher odds for high-efficacy DMDs use (OR = 4.8; 95% CI = (1.5, 16.1)), thinner pRNFL (β = -4.4; 95% CI = (-8.6, -0.2)) and GCIPL (β = -2.9; 95% CI = (-5.9, +0.05)), and higher rates to EDSS ⩾ 3.0 (HR = 4.4; 95% CI = (1.6, 11.8)) and EDSS ⩾ 4.0 (HR = 5.4; 95% CI = (1.1, 27.1)). No overall associations were found for other CSF markers., Conclusion: The presence of OCMB was associated with unfavorable long-term outcomes. OCMB should be determined in RMS to inform long-term prognosis.
- Published
- 2021
- Full Text
- View/download PDF
42. Performance Assessment of the LIAISON® SARS-CoV-2 Antigen Assay On Nasopharyngeal Swabs.
- Author
-
Baj A, Zago C, Tamborini A, Colombo A, Cassani G, Rossi A, Pasciuta R, Novazzi F, Prestia M, Capuano R, Genoni A, Azzi L, Dalla Gasperina D, Spezia PG, Focosi D, and Maggi F
- Subjects
- Humans, Nasopharynx, Pandemics, Saliva, Sensitivity and Specificity, COVID-19, SARS-CoV-2
- Abstract
The SARS-CoV-2 pandemic is ongoing worldwide, causing prolonged pressure on molecular diagnostics. Viral antigen (Ag) assays have several advantages, ranging from lower cost to shorter turnaround time to detection. Given the rare occurrence of low-load viremia, antigen assays for SARSCoV-2 have focused on nasopharyngeal swab and saliva as biological matrices, but their effectiveness must be validated. We assayed here the performances of the novel quantitative Liaison® SARSCoV-2 Ag assay on 119 nasopharyngeal swabs and obtained results were compared with Hologic Panther and Abbott m2000 RT-qPCR. The Ag assay demonstrated a good correlation with viral load, shorter turnaround time, and favorable economics. The best performance was obtained in the acute phase of disease.
- Published
- 2021
43. Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab.
- Author
-
Gallo A, Capuano R, Donnarumma G, Bisecco A, Grimaldi E, Conte M, d'Ambrosio A, Coppola N, Galdiero M, and Tedeschi G
- Subjects
- Antibodies, Monoclonal, Humanized, BNT162 Vaccine, COVID-19 Vaccines, Humans, Immunogenicity, Vaccine, RNA, Messenger, SARS-CoV-2, Spike Glycoprotein, Coronavirus, COVID-19, Multiple Sclerosis drug therapy
- Abstract
Objectives: Several concerns regard the immunogenicity of SARS-CoV-2 vaccines in people with multiple sclerosis (pwMS), since the majority of them is treated with immunomodulating/immunosuppressive disease modifying therapies. Here we report the first data on the humoral response to mRNA SARS-CoV-2 vaccine in a case series of 4 pwMS treated with ocrelizumab (OCR) as compared to a group of healthy subjects (HS)., Methods: We collected serum samples at 0, 14, 21 days after the first dose and 7 days after the second dose of BNT162b2-mRNA-Covid-19 vaccine from 55 health-care workers and 4 relapsing pwMS on OCR, with no history of Covid-19 infection. Sera were tested using the LIAISON®SARS-CoV-2 TrimericS-IgG assay (DiaSorin-S.p.A.) for the detection of IgG antibodies to SARS-CoV-2 spike protein. The anti-spike IgGtiters were expressed in Binding Antibody Units (BAU), an international standard unit., Results: At baseline all subjects were negative for anti-spike IgG. Seven days after the second dose of vaccine all HS mounted a significant humoral response (geometric mean 2010.4 BAU/mL C.I. 95% 1512.7-2672) while the 4 pwMS showed a lower response (range <4.81-175 BAU/mL)., Discussion: Humoral response to BNT162b2-mRNA-vaccine in pwMS treated with OCR was clearly blunted. Further data are urgently needed to confirm and expand these preliminary results and to develop strategies to optimize the response to SARSCoV-2 vaccines in pwMS on OCR., (© 2021. Fondazione Società Italiana di Neurologia.)
- Published
- 2021
- Full Text
- View/download PDF
44. Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal Cancer.
- Author
-
Murdocca M, Torino F, Pucci S, Costantini M, Capuano R, Greggi C, Polidoro C, Somma G, Pasqualetti V, Ketchanji Mougang Y, Catini A, Simone G, Paolesse R, Orlandi A, Mauriello A, Roselli M, Magrini A, Novelli G, Di Natale C, and Sangiuolo FC
- Abstract
Renal cell carcinoma (RCC) represents around 3% of all cancers, within which clear cell RCC (ccRCC) are the most common type (70-75%). The RCC disease regularly progresses asymptomatically and upon presentation is recurrently metastatic, therefore, an early method of detection is necessary. The identification of one or more specific biomarkers measurable in biofluids (i.e., urine) by combined approaches could surely be appropriate for this kind of cancer, especially due to easy obtainability by noninvasive method. OLR1 is a metabolic gene that encodes for the Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), implicated in inflammation, atherosclerosis, ROS, and metabolic disorder-associated carcinogenesis. Specifically, LOX-1 is clearly involved in tumor insurgence and progression of different human cancers. This work reports for the first time the presence of LOX-1 protein in ccRCC urine and its peculiar distribution in tumoral tissues. The urine samples headspace has also been analyzed for the presence of the volatile compounds (VOCs) by SPME-GC/MS and gas sensor array. In particular, it was found by GC/MS analysis that 2-Cyclohexen-1-one,3-methyl-6-(1-methylethyl)- correlates with LOX-1 concentration in urine. The combined approach of VOCs analysis and protein quantification could lead to promising results in terms of diagnostic and prognostic potential for ccRCC tumors.
- Published
- 2021
- Full Text
- View/download PDF
45. Sensor array and gas chromatographic detection of the blood serum volatolomic signature of COVID-19.
- Author
-
Mougang YK, Di Zazzo L, Minieri M, Capuano R, Catini A, Legramante JM, Paolesse R, Bernardini S, and Di Natale C
- Abstract
Volatolomics is gaining consideration as a viable approach to diagnose several diseases, and it also shows promising results to discriminate COVID-19 patients via breath analysis. This paper extends the study of the relationship between volatile compounds (VOCs) and COVID-19 to blood serum. Blood samples were collected from subjects recruited at the emergency department of a large public hospital. The VOCs were analyzed with a gas chromatography mass spectrometer (GC/MS). GC/MS data show that in more than 100 different VOCs, the pattern of abundances of 17 compounds identifies COVID-19 from non-COVID with an accuracy of 89% (sensitivity 94% and specificity 83%). GC/MS analysis was complemented by an array of gas sensors whose data achieved an accuracy of 89% (sensitivity 94% and specificity 80%)., Competing Interests: The authors declare no competing interests., (© 2021 The Authors.)
- Published
- 2021
- Full Text
- View/download PDF
46. Valorization and Mechanical Recycling of Heterogeneous Post-Consumer Polymer Waste through a Mechano-Chemical Process.
- Author
-
Capuano R, Bonadies I, Castaldo R, Cocca M, Gentile G, Protopapa A, Avolio R, and Errico ME
- Abstract
In this paper, a sustainable strategy to valorize and recycle heterogeneous polymer-based post-consumer waste is proposed. This strategy is based on a high-energy mechano-chemical treatment and has been applied to a polyolefin-rich fraction, coded as FIL/S, deriving from household plastic waste collection. This processing, performed in a planetary ball mill, allowed us to obtain fine grinding and, consequently, to induce an intimate mixing of the different polymer fractions and contaminants composing the FIL/S, as demonstrated by SEM analysis. As a result, an improvement in the deformability of the treated material was obtained, recording values for elongation at the break which were two and half times higher than the neat FIL/S. Finally, the addition of small amounts of organic peroxide during mechano-chemical treatment was tested, determining a more homogeneous morphology and a further improvement in mechanical parameters.
- Published
- 2021
- Full Text
- View/download PDF
47. O/W Pickering Emulsions Stabilized with Cellulose Nanofibrils Produced through Different Mechanical Treatments.
- Author
-
Pirozzi A, Capuano R, Avolio R, Gentile G, Ferrari G, and Donsì F
- Abstract
This work aimed at studying the stabilization of O/W Pickering emulsions using nanosized cellulosic material, produced from raw cellulose or tomato pomace through different mechanical treatments, such as ball milling (BM) and high-pressure homogenization (HPH). The cellulose nanofibrils obtained via HPH, which exhibited longer fibers with higher flexibility than those obtained via ball milling, are characterized by lower interfacial tension values and higher viscosity, as well as better emulsion stabilization capability. Emulsion stability tests, carried out at 4 °C for 28 d or under centrifugation at different pH values (2.0, 7.0, and 12.0), revealed that HPH-treated cellulose limited the occurrence of coalescence phenomena and significantly slowed down gravitational separation in comparison with BM-treated cellulose. HPH-treated cellulose was responsible for the formation of a 3D network structure in the continuous phase, entrapping the oil droplets also due to the affinity with the cellulose nanofibrils, whereas BM-treated cellulose produced fibers with a more compact structure, which did adequately cover the oil droplets. HPH-treated tomato pomace gave similar results in terms of particle morphology and interfacial tension, and slightly lower emulsion stabilization capability than HPH-treated cellulose, suggesting that the used mechanical disruption process does not require cellulose isolation for its efficient defibrillation.
- Published
- 2021
- Full Text
- View/download PDF
48. Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab.
- Author
-
Capuano R, Donnarumma G, Bisecco A, Grimaldi E, Conte M, d'Ambrosio A, Matrone F, Risi M, Borgo RM, Altieri M, Giuliano F, Coppola N, Galdiero M, Tedeschi G, and Gallo A
- Abstract
Competing Interests: Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2021
- Full Text
- View/download PDF
49. Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population.
- Author
-
Capuano R, Marchese F, Sica R, Capuano E, Manilia M, Iannone AG, D'Ambrosio A, Bisecco A, Tedeschi G, Gallo A, and Capuano V
- Abstract
Background: Vitamin D (25(OH)D) deficiency is a prevalent condition worldwide. However, the highest prevalence rates of 25(OH)D deficiency have been attributed to regions with higher latitude. A close association between 25(OH)D and cardio-cerebrovascular (CCV) risk factors and major health problems has been identified., Aim: To establish the prevalence of 25(OH)D deficiency and to investigate the relationship between 25(OH)D levels and CCV risk factors (blood cholesterol, triglycerides, glucose concentrations, body mass index, and systolic and diastolic blood pressure) in a cohort representative of Southern Italy., Methods: The prevalence of 25(OH)D levels was evaluated in 1200 subjects aged 25-74 years (600 males and 600 females), enrolled in the "VIP" (from Italian for Irno Valley Prevention ) Project, whereas multiple linear regression analysis was used to determine the relationship between 25(OH)D levels and CCV risk factors., Results: Only 13.3% of females and 11.1% of males showed adequate serum concentrations of 25(OH)D (≥30 ng/ml), while 59.3% of females and 55.1% of males showed 25(OH)D deficient levels (<20 ng/ml). We observed an independent association between 25(OH)D concentrations and metabolic syndrome score, LDL cholesterol, HDL cholesterol, and corrected QT (cQT)., Conclusions: We report a high prevalence of 25(OH)D deficiency across the largest Italian adult population studied so far and, in particular, the first across Southern Italy; furthermore, we provide data on the association between 25(OH)D deficiency and higher CCV risk factors., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2021 Rocco Capuano et al.)
- Published
- 2021
- Full Text
- View/download PDF
50. High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors.
- Author
-
Seguella L, Pesce M, Capuano R, Casano F, Pesce M, Corpetti C, Vincenzi M, Maftei D, Lattanzi R, Del Re A, Sarnelli G, Gulbransen BD, and Esposito G
- Subjects
- Animals, Body Weight, Duodenum metabolism, Male, Mice, Mice, Inbred C57BL, Myenteric Plexus metabolism, Myenteric Plexus pathology, Neuroglia pathology, Neurons metabolism, Neurons pathology, Nodose Ganglion metabolism, Nodose Ganglion pathology, Brain metabolism, Brain pathology, Depression etiology, Diet, High-Fat adverse effects, Duodenum pathology, Mental Disorders etiology, Neuroglia metabolism
- Abstract
Background: Mood and metabolic disorders are interrelated and may share common pathological processes. Autonomic neurons link the brain with the gastrointestinal tract and constitute a likely pathway for peripheral metabolic challenges to affect behaviors controlled by the brain. The activities of neurons along these pathways are regulated by glia, which exhibit phenotypic shifts in response to changes in their microenvironment. How glial changes might contribute to the behavioral effects of consuming a high-fat diet (HFD) is uncertain. Here, we tested the hypothesis that anxiogenic and depressive-like behaviors driven by consuming a HFD involve compromised duodenal barrier integrity and subsequent phenotypic changes to glia and neurons along the gut-brain axis., Methods: C57Bl/6 male mice were exposed to a standard diet or HFD for 20 weeks. Bodyweight was monitored weekly and correlated with mucosa histological damage and duodenal expression of tight junction proteins ZO-1 and occludin at 0, 6, and 20 weeks. The expression of GFAP, TLR-4, BDNF, and DCX were investigated in duodenal myenteric plexus, nodose ganglia, and dentate gyrus of the hippocampus at the same time points. Dendritic spine number was measured in cultured neurons isolated from duodenal myenteric plexuses and hippocampi at weeks 0, 6, and 20. Depressive and anxiety behaviors were also assessed by tail suspension, forced swimming, and open field tests., Results: HFD mice exhibited duodenal mucosa damage with marked infiltration of immune cells and decreased expression of ZO-1 and occludin that coincided with increasing body weight. Glial expression of GFAP and TLR4 increased in parallel in the duodenal myenteric plexuses, nodose ganglia, and hippocampus in a time-dependent manner. Glial changes were associated with a progressive decrease in BDNF, and DCX expression, fewer neuronal dendritic spines, and anxiogenic/depressive symptoms in HFD-treated mice. Fluorocitrate (FC), a glial metabolic poison, abolished these effects both in the enteric and central nervous systems and prevented behavioral alterations at week 20., Conclusions: HFD impairs duodenal barrier integrity and produces behavioral changes consistent with depressive and anxiety phenotypes. HFD-driven changes in both peripheral and central nervous systems are glial-dependent, suggesting a potential glial role in the alteration of the gut-brain signaling that occurs during metabolic disorders and psychiatric co-morbidity.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.